1 Introduction

Open repair of thoracoabdominal aortic aneurysms (TAAAs) is an extraordinary challenge for both vascular surgeons and patients. Consistent outcome data have been reported by high-volume centers with 30-day mortality rates lower than 10% and improved long-term survivals [1]. The development of devices and techniques have allowed total endovascular treatment of TAAA with fenestrated (FEVAR) or branched (BEVAR) endografts [2,3,4,5,6]. Early results are encouraging; a recent meta-analysis has reported a 30-day mortality rate of 8.6%, spinal cord ischemia in 17.3% of cases with permanent consequences in 4.9%, and renal failure in 25.4%. However, anatomic feasibility of BEVAR/FEVAR is still limited, manufacturing times for custom devices are lengthy, and open repair remains the only viable strategy in a number of specific conditions, such as emergency cases, infections, and patients affected by connective tissue disorders.

Recent publications on FEVAR/BEVAR series have highlighted the fate of revascularized visceral vessels (VVs), reporting a progressive loss of stented visceral branches [7]. In addition, a comparison of long-term results with those observed in conventional open repair is still unachievable for such recent technology, which is currently performed in few specialized centers on relatively small groups of patients.

Surprisingly, few data have been reported in the recent literature about the late fate of visceral arteries after open repair of TAAAs [8, 9]. In 2010, Kulik et al. [10] reviewed their TAAA repair experience using a presewn aortic branched graft. Between March 2003 and December 2008, 52 patients with Crawford extent II and III TAAAs underwent surgical repair using a presewn aortic branched graft. The patency rate of the branches to the visceral and renal arteries was 100% and 98%, at 1 and 5 years, respectively. Of the 148 graft branches, two became occluded and four developed stenosis (two patients). One patient required percutaneous stenting of three stenosed branches, and one patient died after acute occlusion of two branches and stenosis of a third. During the follow-up period that extended to 6.3 years, there were ten late deaths. Six patients required reoperation on the aortic graft or contiguous aorta, but no reoperations were required on the visceral abdominal aorta or its branches. The authors concluded that the use of a presewn aortic branched graft is a safe and suitable option for TAAA repair. Another study performed by Shahverdyan et al. [11], in 2013, showed outcomes of long-term bypass graft patency after visceral hybrid repair of thoracoabdominal aortic aneurysms (TAAAs). Between July 2004 and September 2012, 46 patients (67.5 years in median; range 35–88) with TAAAs underwent to the visceral hybrid procedure (164 grafts). The inflow sites of visceral revascularization originated either from the native artery or from aortic prosthetic grafts. The 30-day primary patency of all grafts was 87.9%. The long-term patency remained 87.9 ± 2.7%, 86.1 ± 3.2%, and 86.1 ± 3.2% after 1, 3, and 5 years, respectively. The patency of all hepatic grafts was 100%. The patency of grafts to the superior mesenteric artery was 88.8 ± 4.8% after 1, 3, and 5 years. The patency was 87.2 ± 6%, 87.2 ± 6%, and 87.2 ± 6% for the left renal artery and 76 ± 7%, 69.6 ± 8.8%, and 69.6 ± 8.8% for the right renal artery after 1, 3, and 5 years, respectively. The authors concluded that hybrid repair demonstrates excellent results regarding long-term bypass graft patency of renovisceral arteries except for the right renal artery. In 2015 Youssef et al. [9] showed data of 62 patients (mean age is 66 ± 10 years, 40 men) who had been operated on for TAAA of Crawford types I (8), II (13), III (13), and IV (24) and Safi type V (4). A total of 181 vessels were revascularized by either patch inclusion (n = 147) or selective revascularization (bypass or transposition, n = 34); 48 survived the procedure, resulting in a number of vessels available for follow-up of 154 (patch, 126; selective revascularization, 28). The patency rates for overall, patch, and selective revascularization were 95.2%, 94.2%, and 100% at 5 years and 83.7%, 81.3%, and 100% at 10 years, respectively. The patency rates for the celiac trunk, superior mesenteric artery, and left and right renal artery were 100%, 97.5%, 92.3%, and 90.3% at 5 years. More recently, Kouchoukos et al. [12] showed their experience of 298 branch grafts to the celiac, superior mesenteric, and renal arteries performed in a total of 99 of 130 patients undergoing open thoracoabdominal aortic aneurysm repair. The authors showed a freedom from occlusion of 98%, 97%, and 93%, at 1, 5, and 10 years of follow-up, respectively.

2 San Raffaele Hospital Experience

Between January 2009 and July 2015, 382 patients underwent open TAAA repair at our institution. Patients were selected from a prospectively maintained computerized database and retrospectively reviewed. Demographics and perioperative risk factors are reported in Table 20.1.

Table 20.1 Demographics and preoperative risk factors of 382 TAAA patients

An adequate preoperative assessment of physiological reserve of cardiac, pulmonary, and renal function was used to evaluate operative risks, to plan the best operative strategy, and to consider additional perioperative organ protection strategies. A coronary computed tomography was performed in selected patients with a history of coronary artery disease from 2009 to 2012 and in all elective patients since 2013. A preoperative study was conducted on all patients by a computed tomography angiography (CTA) scan of the thoracoabdominal aorta.

The anatomical extent of the aneurysm was defined according to the Crawford classification [13]. Chronic obstructive pulmonary disease (COPD) included all patients with a grade ≥2 in the GOLD score system [14]. Patients were stratified by chronic kidney disease (CKD) stages according to the NKF-KDOQI (National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative) guidelines [15]. Cerebrovascular disease included all cases with a history of TIA, minor or major stroke, or carotid occlusive disease.

Details of the surgical technique for open repair of TAAAs at our institution have been previously described [12]. The strategy for VV revascularization was customized (Fig. 20.1) according to the following principles: Inclusion in a “beveled” aortic anastomosis or in Carrel patch was favored in case of short distance between the VV ostia; when the aneurysm included the visceral aortic segment, no more than three VVs were normally reimplanted together in a single Carrel patch to avoid the risk of late aneurysm recurrence [16]. A VV originating far from the others was usually reconstructed separately by direct reimplantation on the main aortic graft or by individual graft interposition (6-mm heparin-bonded Dacron or ePTFE). Since 2012, the Gore Hybrid Vascular Graft (W.L. Gore and Associates, Flagstaff, AZ) has been selectively used to perform separate revascularization of one or two VVs allowing for distal sutureless anastomosis. The specific operative technique for this device has been previously described in detail [12]. A separate revascularization of all VVs has always been preferred—in most cases accomplished with presewn multibranched grafts (Coselli graft, Vascutek Terumo, Renfrewshire, UK, or Hemashield Platinum TAAA graft, Maquet, Sunderland, UK)—in case of large aneurysms with excessive distance between all VV ostia, in the event of recurrent aneurysmal disease after previous TAAA surgery, or in patients affected by connective tissue disorders.

Fig. 20.1
figure 1figure 1

Intraoperative views of different techniques for VV reconstruction: (a) Carrel patch including CT (C), SMA (M), and RRA (R). (b) Direct reimplantation of the LRA on the main aortic graft. (c) Revascularization of all VVs using a presewn multibranched graft. (d) Bilateral renal artery revascularization using two Gore Hybrid Vascular Grafts with sutureless distal anastomosis

Intraoperative details included techniques used for VV revascularization and postoperative outcome variables. The follow-up protocol included a physical exam and CTA at 3 and 12 months postoperatively and yearly thereafter. Patients unable to comply with the follow-up protocol were contacted by phone interviews and asked to provide digital supports of their imaging studies when available. Patients not responding to two consecutive attempts of phone interviews were considered lost to follow-up. Restenosis was defined as >50% reduction of the vessel lumen on both arterial and late-phase scans.

Cerebrospinal fluid drainage (CSFD) was used in 343 patients, and left heart bypass (LHBP) in 332. Overall, revascularization involved 1476 VVs: 358 celiac trunks (CT), 379 superior mesenteric arteries (SMA), 366 right renal arteries (RRA), and 373 left renal arteries (LRA). Techniques of VV reconstruction and associated procedures—endarterectomy or stenting—are reported in Table 20.2.

Table 20.2 Techniques used for reconstruction of visceral vessels in 382 TAAA patients

Perioperative results are summarized in Table 20.3. The in-hospital mortality was 7.6% (29 patients), including five intraoperative deaths. Complications occurred in 26.8% of patients (n = 102). Among 353 early-surviving patients, 15 were lost to follow-up. The mean length of follow-up was 22 ± 17 months.

Table 20.3 Perioperative results in 382 TAAA patients

General survival was 87% at 1 year, 84% at 2 years, 75% at 3 years, and 65% at 5 years (Fig. 20.2). No instances of bowel ischemia were recorded during follow-up. Eight patients developed late- onset renal failure requiring dialysis. Estimates for reintervention on VVs were 1.2%, 6.3%, and 17% at 1, 3, and 5 years, respectively (Fig. 20.3). All patients requiring reinterventions on VVs presented with asymptomatic restenosis and were treated by means of percutaneous stenting.

Fig. 20.2
figure 2figure 2

Kaplan-Meier curve of overall survival in 338 patients

Fig. 20.3
figure 3figure 3

Kaplan-Meier curve of freedom from reinterventions on VVs in 338 patients

Of 338 patients available at follow-up, 247 had adequate imaging studies for analysis of VV patency. Among these, 952 VVs were analyzed (229 CT, 245 SMA, 238 RRA, and 240 LRA). Overall patency of analyzed VVs was 98% at 1 year, 95% at 3 years, and 94% at 5 years. An analysis of available images provided the following patency rate of individual vessels at 1, 3, and 5 years: 99%, 98%, and 98% for CT; 100%, 100%, and 100% for SMA; 100%, 96%, and 96% for RRA; and 91%, 87%, and 82% for LRA (Fig. 20.4a). Compared with other VVs, the LRA showed a trend of significantly reduced patency in time (log rank [Mantel-Cox] test, P < 0.0001). Freedom from restenosis or occlusion at 1, 3, and 5 years was 98%, 94%, and 94% for CT; 100%, 99%, and 99% for SMA; 99%, 93%, and 90% for RRA; and 91%, 82%, and 77% for LRA (log rank [Mantel-Cox] test, P < 0.0001, Fig. 20.4b).

Fig. 20.4
figure 4figure 4

Kaplan-Meier curves of (a) VV patency and (b) VV freedom from restenosis/occlusion in 247 patients

The group of 247 patients with available follow-up imaging was divided into three subgroups according to the VV reconstruction technique: patients with all VVs included in Carrel patch or in a “beveled” anastomosis (Group A, 94 patients), patients with 2 or 3 VVs included in Carrel patch and 1 separately reimplanted (Group B, 127 patients), and patients with all VVs reimplanted with separate revascularization (Group C, 26 patients). Freedom from any VV occlusion at 1 and 3 years was 95% and 87% for Group A, 89% and 79% for Group B, and 92% and 92% for Group C (P = 0.13, Fig. 20.5).

Fig. 20.5
figure 5figure 5

Kaplan-Meier curves of freedom from any VV occlusion based on reconstructive techniques in 247 patients

3 Discussion

Open repair has historically been considered the gold standard for treatment of TAAAs. Due to severe surgical trauma and early complication rates—even in experienced hands—total endovascular repair and hybrid techniques have been proposed as alternative options in patients considered at unacceptable high risk for conventional surgery.

Hybrid approach (surgical debranching of the abdominal aorta with retrograde bypass and stent grafting) has been proposed as an alternative option to patients who are unfit for surgery [15]. Although such a procedure avoids thoracolaparotomy, single-lung ventilation, aortic cross-clamping, and extracorporeal perfusion, early results of several series reported mortality rates ranging between 2.3% and 24% [13, 14] with significant morbidity (spinal cord ischemia up 8.4% and renal failure requiring dialysis up to 26.2%) [13]. Moreover, the obstruction of visceral bypass is a relevant event in the midterm, affecting almost one third of cases with heavy clinical consequences, namely, emergency reintervention for bowel ischemia or permanent dialysis [13].

In recent years, the development of devices and techniques have allowed total endovascular treatment of TAAA with fenestrated (FEVAR) or branched (BEVAR) endografts [17, 18]. Early results are encouraging; a recent meta-analysis has reported a 30-day mortality rate of 8.6%, spinal cord ischemia in 17.3% of cases with permanent consequences in 4.9%, and renal failure in 25.4% [18].

However, anatomic feasibility of BEVAR/FEVAR is still limited, manufacturing times for custom devices are lengthy, and open repair remains the only viable strategy in a number of specific conditions, such as emergency cases, infections, and patients affected by connective tissue disorders. Moreover, conventional surgery has yielded durable results, and a reliable comparison with long-term results of such recent endovascular techniques is still unachievable [19,20,21,22].

Moreover, although total endovascular repair has been performed since 2005 and there are centers with vast experience, long-term data about target vessel patency are still lacking. With a composite end point of branch instability (occlusion, migration, need for secondary intervention), results from the Cleveland Clinic have shown a rate of 70% at 5 years after fenestrated and branched endovascular repair of TAAA [23]. For hybrid TAAA repair, patency rates reported are in the range of 97% at 1 year [15] and 96% at 3 years [24]. Bianchini Massoni et al. performed a multicenter study providing patency data extending up to 4 years, and there, a patency of 79% was noted [19].

Our findings confirm that, in high-volume centers, perioperative mortality and morbidity rates are acceptable, and open surgery results are durable with high survival rates also at midterm follow-up.

The reconstruction strategy of VV represents a critical point in TAAA surgical repair, often requiring complex technical skills. Early failure of reconstructed branches may result in catastrophic outcomes. A number of techniques for VV reconstruction were described in the past by several authors. Inclusion in a visceral aortic patch (VAP) is the most commonly used strategy to obtain simultaneous revascularizations of multiple VVs, decreasing the global number of anastomoses. Separate reattachment is frequently required when VV ostia are distant, and this particularly applies to the LRA. Separate reattachment of VVs may be performed by direct reimplantation on the main aortic graft or by graft interposition. Recently, we have reported the use of “hybrid” grafts allowing to perform distal sutureless anastomosis as a useful tool for VV revascularization during TAAA open repair [25]. Alternatively, the use of presewn aortic branched grafts allows to separately revascularize each VV, and, for this reason, it is considered the preferred choice in most young patients affected by connective tissue disorders [10]. There are very few data available from the literature about the fate of reconstructed VV and the possible effects of the surgical technique used. Our overall late patency results (94% at 5 years) favorably compare with other series reporting a total patency of the reimplanted vessels of 95.4% and 97% at 5 years [8, 9].

In our experience, late patency rates were not apparently biased by the technique adopted. Interestingly, our study showed that the LRA has a significantly lower patency at all time points as compared to the other VVs. The cause of this finding is not clear, but it can be hypothesized that the intraoperative visceral rotation and subsequent repositioning may play a crucial role leading to kinking or angulation of the revascularized artery. Moreover, the LRA was most often involved by adjunctive procedures, such as endarterectomy or direct stenting.

Late patency of visceral branches following total endovascular TAAA repair (FEVAR and/or BEVAR) is an open issue. Different groups reported excellent early patency rates, followed in the midterm by a slow but progressive loss of visceral branches [1, 26, 27]. Late occlusion involves VVs at different rates, with a significant prevalence of renal arteries compared to other vessels. Renal branch occlusion has been observed in 8–9.6% of cases at midterm follow-up [7, 28]. Along with the high individual anatomic variability of the renal artery angle compared with other VVs, additional factors—e.g., respiratory motion and small vessel size—could have an adjunctive stress effect on stents.

The possible role of different devices employed in VV endovascular reconstruction has not been confirmed in a multicentric series [7], while the mean artery length and anatomic location were considered more likely associated with a poor branch outcome, and this finding could be a touchpoint with possible mechanical factors influencing observed late fate of LRA after open repair—particularly when presewn grafts are used [28].

Further studies are required to evaluate long-term survival and patency rates of visceral branches after total endovascular TAAA repair. Our series of 382 consecutive patients treated with open surgical repair provided early results in line with other high-volume centers and remarkable late patency rates for VV reconstruction. Based on a group of 247 patients and 952 VV available for imaging study, this is, to the best of our knowledge, the largest series of surgical TAAA patients with long-term imaging evaluation of VV. This could be a useful benchmark for comparisons with future endovascular results.